Xu Ming, Vice President of China Chamber of Commerce for Import & Export of Medicines and Health Products
Theme: Pharmaceutical Industry is now under Creative Destruction
The pharmaceutical industry is now under the creative destruction, i.e., "Schumpeterization". Connotations of the industry competitions, such as in massive health, big data and macromolecule, center more on the utilization and integration of transboundary resources and a new medical revolution is being quietly proceeded. As one future development trend, the biotechnological drugs will be the industry investment hot spot of 2015-2020. There are currently many challenges in Chinese biopharmaceutical industry: the industry development is accelerated, but the overall layout planning shall be improved; the financing system of the biopharmaceutical industry is not yet comprehensively formed; the R&D foundation is still weak and there are many difficulties with the industrialized development; there are still deficiencies of the international network of the biopharmaceutical outsourcing services; the industrial promotion and regulatory policies do not promptly follow up or form combined effect.
Zhuo Yongqing, CEO of R&D-based Pharmaceutical Association Committee (RDPAC) of China Association of Enterprises with Foreign Investment
Theme: To Create a World-leading Innovative Biotechnological Pharmaceutical Industry in China
It is strategically important to accelerate the development of the biotechnological pharmaceutical industry so as to bring about value for the patients, pharmaceutical industry and China's economy. Value for the patients: meet medical demands, promote innovation and support transition of China's economy to the knowledge-intensive economy; value for the pharmaceutical industry: the biotechnological drugs have solved many major disease issues that were difficult to conquer and have improved life of the patients; value for China's economy: the biotechnological drugs are an important driving force for the future growth of the global pharmaceutical industry.
Zeng Bing, Deputy General Manager of China National Pharmaceutical Group Corporation
Theme: Strengthen the International Cooperation to Promote the Sound and Fast Development of Chinese Biopharmaceutical Industry
The development trends of the global pharmaceutical industry: the market demands drive the industry to stably grow, the input-output proportion of new drugs decreases, there are new changes in product patterns, and the alliance cooperation has become an important R&D mode. Advantages of Sino-foreign cooperation: realize resource sharing and complementary advantages of each party, reduce fiscal expenditure and operation cost, and adapt to the international market better and faster.
